Teva forms drug research partnerships with Israeli institutes
Teva has entered into a collaboration agreement with the Weizmann Institute of Science’s commercial arm...
Read More...
Focus:
Middle-east-and-africa
-
![Mapi Pharma Sterile Injectable]()
Mapi Pharma’s Sterile Injectable Production Plant in Jerusalem
Israel-based clinical-stage pharmaceutical company Mapi Pharma has announced the development of a new sterile injectable...
Read More...
-
![Pharma price-fixing]()
Trouble at Teva: US price-fixing lawsuit adds to generic giant’s woes
Israeli generics giant Teva, among other firms, has been hit by a 44-state lawsuit alleging...
Read More...
-
![Ebola vaccination]()
WHO calls for expanded Ebola vaccination after cases rise in Congo
The World Health Organization (WHO) has recommended that the target area for Ebola vaccine administration...
Read More...
-
![Teva discontinues trial of Ajovy]()
Teva discontinues trial of Ajovy for episodic cluster headache
Israeli pharmaceutical company Teva has announced the discontinuation of its ENFORCE Phase III trial programme...
Read More...
-
![BiomX IBD acne]()
BiomX raises funds to advance drug candidates for acne and IBD
Israeli drug discovery firm BiomX has raised funds in a series B round to advance...
Read More...
-
Deals and M&As this week: Alnylam Pharmaceuticals, Novartis
Alnylam Pharmaceuticals has entered an agreement with Medison Pharma to commercialise its RNAi therapeutic Onpattro...
Read More...
-
Alnylam partners with Medison to offer Onpattro in Israel
US-based Alnylam Pharmaceuticals has signed an exclusive agreement with Medison Pharma to commercialise its RNAi...
Read More...
-
M&As this week: ProKidney, Quest Products, Gencore Pacific
ProKidney has acquired inRegen and its subsidiary Twin City Bio.
Read More...
-
![CytoReason]()
Pfizer partners with CytoReason on immune system models for drug discovery
Israeli-machine learning company CytoReason has announced it has signed a collaboration agreement with Pfizer in...
Read More...
Close
Close
Close
Go Top
